KUALA LUMPUR, Feb 22 (Bernama) -- Dexcom Inc, a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, has launched its Dexcom G6 CGM System in Singapore for people with diabetes ages two years and older, including pregnant women.
The company also announced the appointment of DKSH Singapore Pte Ltd as sales, marketing, and distribution service provider.
"The launch of Dexcom G6 in Singapore is a significant milestone for our company, marks the first time Dexcom CGM is available to people living with diabetes in Southeast Asia.
“With the recent opening of our regional headquarters in Singapore, we look forward to bringing Dexcom CGM to additional markets in the region in the near future,” said Dexcom, Asia-Pacific vice president, Scott Moss in a statement.
The Dexcom G6 uses a small, wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a receiver or compatible smart device, enabling patients to receive real-time glucose data without the need to prick their finger.
The system also offers customisable alerts and alarms to help avoid dangerous low and high blood sugar events.
The Dexcom G6 app for compatible iOS and Android devices also allows patients to share their glucose information with up to 10 followers, enabling family, loved ones and healthcare providers to remotely monitor patients for extra peace of mind.
Features of Dexcom G6 that empower users to take control of their health include elimination of fingersticks for calibration and diabetes treatment decisions; 10-day sensor allowing for longer wear; and a slim transmitter with a lower profile for more discreet wearability.
Dexcom G6 CGM received its approval from Singapore’s Health Sciences Authority (HSA) late last year and can now be accessed by Singaporeans this month.
-- BERNAMA
No comments:
Post a Comment